Search Results

You are looking at 41 - 50 of 457 items for :

  • Refine by Access: Open Access content only x
Clear All
Open access

Natalie Su-Jing Yap, Richard Maher, and Diana Louise Learoyd

recurrences after initial surgery (1, 2) , and this occurs predominantly in the cervical lymph nodes. Ultrasonography has high sensitivity in the detection of cervical metastases but low specificity due to frequently occurring benign lymphadenopathies (3

Open access

Julie M Silverstein

psychosocial profile (14) . This includes increased anxiety, body image distortion, depression, impaired short- and long-term memory, and social withdrawal. Surgery, medical therapy, and radiotherapy are the current multimodal treatment options available for

Open access

Emmanuelle Motte, Anya Rothenbuhler, Stephan Gaillard, Najiba Lahlou, Cécile Teinturier, Régis Coutant, and Agnès Linglart

suspected ( 9 ), the treatment remains a challenge. The gold standard treatment for both pediatric and adult patients with CD is transsphenoidal surgery (TSS) with selective microadenomectomy, but the failure rate is about 25–50% ( 10 , 11 , 12 , 13 , 14

Open access

Jan Calissendorff and Henrik Falhammar

sustained in around 50–55% ( 1 ). Another option is surgery, which is often considered in recurrence of GD after medical therapy, in patients with large goitres, and when pregnancy is planned in the near future. The third possibility is treatment with

Open access

Leyre Lorente-Poch, Sílvia Rifà-Terricabras, Juan José Sancho, Danilo Torselli-Valladares, Sofia González-Ortiz, and Antonio Sitges-Serra

secondary hyperparathyroidism were excluded. All the procedures were performed by the same team of experienced endocrine surgeons at the Hospital Universitari del Mar in Barcelona, Spain, a referral center for Endocrine Surgery. Figure 1 Patient flow

Open access

Helle Døssing, Finn Noe Bennedbæk, and Laszlo Hegedüs

%) patients after LT. Nineteen patients (17 within 6 months and 2 patients after 36 months) had surgery after LT and the median follow-up for the remaining 91 patients was 45 months (range: 12–134). Figure 1 Algorithm for enrolment of study patients, in

Open access

Pablo Abellán-Galiana, Carmen Fajardo-Montañana, Pedro Riesgo-Suárez, Marcelino Pérez-Bermejo, Celia Ríos-Pérez, and José Gómez-Vela

Introduction Transsphenoidal surgery is the treatment of choice in Cushing’s disease (CD). Following removal of the pituitary adenoma, the remission rate varies between 25 and 100% (mean 77.8%, median 78.7%), and the recurrence rate ranges

Open access

R Walia, M Singla, K Vaiphei, S Kumar, and A Bhansali

virilization of external genitalia, prospects of restoring normal appearance of external genitalia and fertility and parent’s/patient’s preferences. Genital surgery is often required; however, the type and time of surgery are still debatable ( 5 ). Most of the

Open access

Daniel Bell, Julia Hale, Cara Go, Ben G Challis, Tilak Das, Brian Fish, and Ruth T Casey

treatment option for pHPT is parathyroid surgery (PTX), which is indicated according to international guidelines in those with symptomatic hypercalcaemia, renal/skeletal complications or a diagnosis of pHPT in patients less than 50 years ( 2 ). Some patients

Open access

Bernardo Maia, Leandro Kasuki, and Mônica R Gadelha

therapy and radiotherapy ( 4 , 6 , 7 ). Current treatments Surgical treatment Surgery is the gold standard treatment of acromegaly since it represents the only therapy capable of rapidly curing acromegaly ( 4 ). With experienced pituitary